| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef3e73bf82e05dd388bd59b6da624736 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-225 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04 |
| filingDate |
1981-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1982-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2090846-A |
| titleOfInvention |
Anti-tumor polysaccharide |
| abstract |
A high molecular weight polysaccharide MPS-80 is obtained by culturing high molecular weight polysaccharide MPS-80-producing bacteria belonging to genera Lactobacillus or Streptococcus. The new high molecular polysaccharide MPS-80 has an excellent anti-tumor effect, and it is expected for the utilization as anti-tumor agent. Bacteria specified for use in the process are Lactobacillus jugurti no. 851, FERM BP-66 (FERM-P no. 5851) and Streptococcus thermophilus no. 127, FERM BP-65 (FERM-P no. 5850). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0132981-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5484715-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0459367-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4824945-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4833129-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0132981-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5424201-A |
| priorityDate |
1981-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |